Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Parvoviridae Infections | 1 | 2021 | 35 | 0.780 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 2021 | 83 | 0.770 |
Why?
|
Proto-Oncogene Proteins | 4 | 2021 | 4554 | 0.700 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2021 | 142 | 0.680 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2019 | 380 | 0.610 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2023 | 1519 | 0.610 |
Why?
|
Peptides, Cyclic | 1 | 2016 | 400 | 0.480 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1581 | 0.460 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2021 | 2455 | 0.420 |
Why?
|
Hematopoietic Stem Cells | 1 | 2024 | 3386 | 0.390 |
Why?
|
Graft vs Host Disease | 1 | 2023 | 2957 | 0.370 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2024 | 3523 | 0.350 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2019 | 2948 | 0.330 |
Why?
|
Proteins | 1 | 2021 | 6103 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 4 | 2017 | 1434 | 0.260 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5442 | 0.260 |
Why?
|
bcl-2-Associated X Protein | 2 | 2017 | 295 | 0.250 |
Why?
|
Vincristine | 3 | 2013 | 1039 | 0.220 |
Why?
|
Leukemoid Reaction | 1 | 2022 | 15 | 0.210 |
Why?
|
Hemoglobins, Abnormal | 1 | 2022 | 119 | 0.210 |
Why?
|
Plasma Cell Granuloma, Pulmonary | 1 | 2021 | 13 | 0.210 |
Why?
|
gamma-Globins | 1 | 2022 | 95 | 0.210 |
Why?
|
Glucocorticoids | 2 | 2021 | 2107 | 0.200 |
Why?
|
Anemia, Hemolytic | 1 | 2022 | 168 | 0.200 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5853 | 0.200 |
Why?
|
Parvovirus B19, Human | 1 | 2021 | 38 | 0.190 |
Why?
|
Methylprednisolone | 1 | 2021 | 387 | 0.170 |
Why?
|
Apoptosis | 8 | 2019 | 9727 | 0.170 |
Why?
|
Hemolysis | 1 | 2021 | 420 | 0.170 |
Why?
|
Antineoplastic Agents | 8 | 2019 | 13695 | 0.160 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 2017 | 84 | 0.150 |
Why?
|
Phenyl Ethers | 1 | 2017 | 58 | 0.150 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13102 | 0.150 |
Why?
|
Rhabdoid Tumor | 1 | 2019 | 212 | 0.140 |
Why?
|
Rare Diseases | 1 | 2021 | 553 | 0.140 |
Why?
|
Cell Cycle Proteins | 2 | 2019 | 3462 | 0.140 |
Why?
|
Erythrocyte Transfusion | 1 | 2021 | 565 | 0.140 |
Why?
|
Doxorubicin | 5 | 2013 | 2234 | 0.130 |
Why?
|
Bone Marrow Cells | 1 | 2023 | 2513 | 0.130 |
Why?
|
Protein Structure, Secondary | 2 | 2015 | 1246 | 0.130 |
Why?
|
Hydrocarbons | 1 | 2015 | 106 | 0.130 |
Why?
|
Down Syndrome | 1 | 2022 | 880 | 0.120 |
Why?
|
Nerve Degeneration | 1 | 2017 | 748 | 0.110 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 197 | 0.100 |
Why?
|
Vinca Alkaloids | 1 | 2011 | 35 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1580 | 0.100 |
Why?
|
Dexamethasone | 3 | 2013 | 1951 | 0.100 |
Why?
|
Recurrence | 1 | 2023 | 8340 | 0.100 |
Why?
|
Caspase 8 | 1 | 2011 | 195 | 0.100 |
Why?
|
Protein Structure, Tertiary | 2 | 2015 | 3846 | 0.100 |
Why?
|
Anthracyclines | 1 | 2013 | 288 | 0.100 |
Why?
|
Child | 5 | 2023 | 77709 | 0.090 |
Why?
|
Osteosarcoma | 1 | 2016 | 881 | 0.090 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2727 | 0.090 |
Why?
|
Paclitaxel | 1 | 2017 | 1708 | 0.090 |
Why?
|
Protein Binding | 3 | 2017 | 9386 | 0.090 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1157 | 0.090 |
Why?
|
Axons | 1 | 2017 | 1684 | 0.090 |
Why?
|
Genotype | 1 | 2024 | 12951 | 0.080 |
Why?
|
Cell Line, Tumor | 5 | 2016 | 16689 | 0.080 |
Why?
|
Mice | 9 | 2023 | 81183 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11483 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12959 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2019 | 3557 | 0.070 |
Why?
|
Humans | 16 | 2024 | 744343 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2016 | 2529 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2021 | 5256 | 0.060 |
Why?
|
DNA Damage | 1 | 2013 | 2432 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9239 | 0.060 |
Why?
|
Peptides | 1 | 2015 | 4409 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8428 | 0.050 |
Why?
|
Tumor Cells, Cultured | 3 | 2019 | 6314 | 0.050 |
Why?
|
beta-Globins | 1 | 2022 | 113 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10638 | 0.050 |
Why?
|
Animals | 9 | 2023 | 168757 | 0.050 |
Why?
|
Jurkat Cells | 2 | 2012 | 743 | 0.050 |
Why?
|
Amino Acid Sequence | 3 | 2017 | 13815 | 0.040 |
Why?
|
Mice, Nude | 2 | 2019 | 3689 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2015 | 7880 | 0.040 |
Why?
|
Neoplasm Transplantation | 2 | 2013 | 2085 | 0.040 |
Why?
|
Drug Synergism | 2 | 2013 | 1792 | 0.040 |
Why?
|
Mice, Inbred NOD | 2 | 2012 | 1878 | 0.040 |
Why?
|
Mice, SCID | 2 | 2012 | 2716 | 0.040 |
Why?
|
Models, Molecular | 2 | 2017 | 5456 | 0.030 |
Why?
|
Heterozygote | 1 | 2022 | 2804 | 0.030 |
Why?
|
Methotrexate | 2 | 2013 | 1727 | 0.030 |
Why?
|
Deuterium Exchange Measurement | 1 | 2015 | 30 | 0.030 |
Why?
|
Ganglia, Spinal | 1 | 2017 | 519 | 0.030 |
Why?
|
Male | 3 | 2021 | 350118 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2013 | 11524 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2017 | 624 | 0.030 |
Why?
|
Drug Antagonism | 1 | 2013 | 50 | 0.030 |
Why?
|
Cyclin B | 1 | 2013 | 108 | 0.030 |
Why?
|
Pentacyclic Triterpenes | 1 | 2012 | 37 | 0.030 |
Why?
|
Cyclin E | 1 | 2013 | 172 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2013 | 408 | 0.030 |
Why?
|
Thioguanine | 1 | 2011 | 46 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2022 | 25625 | 0.030 |
Why?
|
Triterpenes | 1 | 2012 | 80 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2015 | 18111 | 0.030 |
Why?
|
Gamma Rays | 1 | 2013 | 320 | 0.030 |
Why?
|
Female | 5 | 2021 | 380194 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3597 | 0.020 |
Why?
|
Cytarabine | 1 | 2011 | 692 | 0.020 |
Why?
|
DNA Primers | 1 | 2013 | 2892 | 0.020 |
Why?
|
Adult | 1 | 2023 | 214055 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2011 | 1827 | 0.020 |
Why?
|
HeLa Cells | 1 | 2015 | 3128 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1655 | 0.020 |
Why?
|
Mitosis | 1 | 2013 | 1208 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2011 | 692 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2015 | 2203 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2017 | 3760 | 0.020 |
Why?
|
Drug Combinations | 1 | 2012 | 1959 | 0.020 |
Why?
|
Protein Conformation | 1 | 2015 | 4011 | 0.020 |
Why?
|
Cell Death | 1 | 2012 | 1706 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8301 | 0.020 |
Why?
|
Binding Sites | 1 | 2015 | 6114 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2219 | 0.020 |
Why?
|
Cell Division | 1 | 2013 | 4568 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 3701 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.020 |
Why?
|
Mutation | 2 | 2022 | 29786 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3505 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5179 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 4933 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2967 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10481 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2889 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14557 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12797 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6489 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19229 | 0.010 |
Why?
|
Cell Survival | 1 | 2011 | 5882 | 0.010 |
Why?
|
Rats | 1 | 2017 | 24260 | 0.010 |
Why?
|
Cell Line | 1 | 2015 | 15997 | 0.010 |
Why?
|
Infant | 1 | 2022 | 35136 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 21827 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2013 | 5172 | 0.010 |
Why?
|
Signal Transduction | 1 | 2011 | 23403 | 0.000 |
Why?
|
Concepts
(140)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_